BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 913779)

  • 1. Mechanism of action of somatostatin: growth-hormone release and [45Ca]calcium ion translocation caused by increasing the extracellular potassium ion concentration [proceedings].
    Bicknell RJ; Schofield JG
    Biochem Soc Trans; 1977; 5(4):1051-3. PubMed ID: 913779
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of somatostatin and verapamil on growth hormone release and 45Ca fluxes.
    Schofield JG; Bicknell RJ
    Mol Cell Endocrinol; 1978 Jan; 9(3):255-68. PubMed ID: 624436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of somatostatin: growth-hormone release [45Ca]calcium ion efflux and cyclic nucleotide metabolism of bovine anterior-pituitary slices in the presence of prostaglandin E2 and 1-methyl-3-isobutylxanthine.
    Bicknell RJ; Young PW; Schofield JG; Albano J
    Biochem Soc Trans; 1977; 5(1):219-22. PubMed ID: 196956
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of somatostatin: inhibition of ionophore A23187-induced release of growth hormone from dispersed bovine pituitary cells.
    Bicknell RJ; Schofield JG
    FEBS Lett; 1976 Sep; 68(1):23-6. PubMed ID: 786734
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition by somatostatin of bovine growth hormone secretion following sodium channel activation.
    Bicknell RJ; Schofield JG
    J Physiol; 1981 Jul; 316():85-96. PubMed ID: 6119362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium modification of the somatostatin effect on stimulated rat growth hormone release.
    Stachura ME
    Endocrinology; 1981 Mar; 108(3):1027-34. PubMed ID: 6109624
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of growth hormone inhibiting factor (somatostatin) on the release of growth hormone and prolactin from pituitaries of the domestic fowl in vitro.
    Hall TR; Chadwick A
    J Endocrinol; 1976 Jan; 68(1):163-4. PubMed ID: 815507
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone.
    Brazeau P; Vale W; Rivier J; Guillemin R
    Life Sci; 1974 Jul; 15(2):351-7. PubMed ID: 4549923
    [No Abstract]   [Full Text] [Related]  

  • 9. Free intracellular Ca2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin.
    Lussier BT; French MB; Moor BC; Kraicer J
    Endocrinology; 1991 Jan; 128(1):592-603. PubMed ID: 1670926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified growth hormone releasing factor increases 45 Ca uptake into pituitary cells.
    Milligan JV; Kraicer J; Fawcett CP; Illner P
    Can J Physiol Pharmacol; 1972 Jun; 50(6):613-7. PubMed ID: 4558617
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin inhibition of teleost growth hormone secretion.
    Fryer JN; Nishioka RS; Bern HA
    Gen Comp Endocrinol; 1979 Oct; 39(2):244-6. PubMed ID: 499752
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of growth hormone from ox pituitary slices after pronase treatment.
    Schofield JG; Orci L
    J Cell Biol; 1975 Apr; 65(1):223-7. PubMed ID: 1127011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of growth hormone release in vivo and in vitro by alpha-MSH.
    Zahnd GR; Vecsey A
    Front Horm Res; 1977; 4():188-92. PubMed ID: 566224
    [No Abstract]   [Full Text] [Related]  

  • 14. Two types of voltage-dependent calcium current in rat somatotrophs are reduced by somatostatin.
    Chen C; Zhang J; Vincent JD; Israel JM
    J Physiol; 1990 Jun; 425():29-42. PubMed ID: 1976802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3-isobutyl-1-methylxanthine.
    Schofield JG; Mira-Moser F; Schorderet M; Orci L
    FEBS Lett; 1974 Sep; 46(1):171-4. PubMed ID: 4371679
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin pretreatment facilitates GRF-induced GH release and increase in free calcium in pituitary cells.
    Soya H; Suzuki M; Kato M
    Biochem Biophys Res Commun; 1990 Oct; 172(1):276-81. PubMed ID: 1977387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro.
    Tapia-Arancibia L; Arancibia S; Bluet-Pajot MT; Enjalbert A; Epelbaum J; Priam M; Kordon C
    Eur J Pharmacol; 1980 May; 63(2-3):235-6. PubMed ID: 6103817
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary 45 Ca ion uptake and release of ACTH, GH, and TSH: effect of verapamil.
    Eto S; Wood JM; Hutchins M; Fleischer N
    Am J Physiol; 1974 Jun; 226(6):1315-20. PubMed ID: 4365294
    [No Abstract]   [Full Text] [Related]  

  • 19. Cofactor requirements for the stimulation of ox growth hormone release in vitro.
    Kerbey AL; McPherson M; Sheterline P; Schofield JG
    Symp Soc Exp Biol; 1974; (28):375-97. PubMed ID: 4375863
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on growth hormone secretion. 3. Inhibition of prostaglandin, theophylline and cyclic amp stimulated growth hormone release by valinomycin in vitro.
    Hertelendy F; Peake G; Todd H
    Biochem Biophys Res Commun; 1971 Jul; 44(2):253-60. PubMed ID: 4334132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.